BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND SMAD3, JV15-2, 4088, ENSG00000166949, P84022, Smad3, MADH3, HsT17436, Smad 3, DKFZp686J10186, HSPC193, DKFZP586N0721, MGC60396 AND Treatment
25 results:

  • 1. RNA
    Tan B; Zhou K; Liu W; Prince E; Qing Y; Li Y; Han L; Qin X; Su R; Pokharel SP; Yang L; Zhao Z; Shen C; Li W; Chen Z; Zhang Z; Deng X; Small A; Wang K; Leung K; Chen CW; Shen B; Chen J
    Theranostics; 2022; 12(13):5727-5743. PubMed ID: 35966596
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. HLF regulates ferroptosis, development and chemoresistance of triple-negative breast cancer by activating tumor cell-macrophage crosstalk.
    Li H; Yang P; Wang J; Zhang J; Ma Q; Jiang Y; Wu Y; Han T; Xiang D
    J Hematol Oncol; 2022 Jan; 15(1):2. PubMed ID: 34991659
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Inhibition of TGF-β1 on Gli2 expression was promoted by TNF-α in primary leukemia cells.
    Li Z; Mao S; Zhang N
    J Recept Signal Transduct Res; 2022 Apr; 42(2):169-172. PubMed ID: 33615977
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Miltefosine suppression of Pten null T-ALL leukemia via β-catenin degradation through inhibition of pT308-Akt and TGFβ1/smad3.
    Zhang Y; Lee S; Xu W
    Biochem Biophys Res Commun; 2020 Apr; 524(4):1018-1024. PubMed ID: 32063363
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Blockade of TGF-β/smad signaling by the small compound HPH-15 ameliorates experimental skin fibrosis.
    Luong VH; Chino T; Oyama N; Matsushita T; Sasaki Y; Ogura D; Niwa SI; Biswas T; Hamasaki A; Fujita M; Okamoto Y; Otsuka M; Ihn H; Hasegawa M
    Arthritis Res Ther; 2018 Mar; 20(1):46. PubMed ID: 29544542
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Effect and mechanism of RNAi targeting WWTR1 on biological activity of gastric cancer cells SGC7901.
    Li Y; Yang FL; Zhu CF; Tang LM
    Mol Med Rep; 2018 Feb; 17(2):2853-2860. PubMed ID: 29207147
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Homoharringtonine targets smad3 and TGF-β pathway to inhibit the proliferation of acute myeloid leukemia cells.
    Chen J; Mu Q; Li X; Yin X; Yu M; Jin J; Li C; Zhou Y; Zhou J; Suo S; Lu D; Jin J
    Oncotarget; 2017 Jun; 8(25):40318-40326. PubMed ID: 28454099
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Inhibition effects of lamellarin D on human leukemia K562 cell proliferation and underlying mechanisms.
    Zhang N; Wang D; Zhu Y; Wang J; Lin H
    Asian Pac J Cancer Prev; 2014; 15(22):9915-9. PubMed ID: 25520128
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Inhibition of the cancer stem cells-like properties by arsenic trioxide, involved in the attenuation of endogenous transforming growth factor beta signal.
    Li Y; Jiang F; Liu Q; Shen J; Wang X; Li Z; Zhang J; Lu X
    Toxicol Sci; 2015 Jan; 143(1):156-64. PubMed ID: 25304214
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Inhibition of TGF-β/smad3/NF-κB signaling by microRNA-491 is involved in arsenic trioxide-induced anti-angiogenesis in hepatocellular carcinoma cells.
    Jiang F; Wang X; Liu Q; Shen J; Li Z; Li Y; Zhang J
    Toxicol Lett; 2014 Nov; 231(1):55-61. PubMed ID: 25196641
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Montelukast suppresses epithelial to mesenchymal transition of bronchial epithelial cells induced by eosinophils.
    Hosoki K; Kainuma K; Toda M; Harada E; Chelakkot-Govindalayathila AL; Roeen Z; Nagao M; D'Alessandro-Gabazza CN; Fujisawa T; Gabazza EC
    Biochem Biophys Res Commun; 2014 Jul; 449(3):351-6. PubMed ID: 24845378
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Arsenic trioxide inhibits transforming growth factor-β1-induced fibroblast to myofibroblast differentiation in vitro and bleomycin induced lung fibrosis in vivo.
    Luo F; Zhuang Y; Sides MD; Sanchez CG; Shan B; White ES; Lasky JA
    Respir Res; 2014 Apr; 15(1):51. PubMed ID: 24762191
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Eosinophils promote epithelial to mesenchymal transition of bronchial epithelial cells.
    Yasukawa A; Hosoki K; Toda M; Miyake Y; Matsushima Y; Matsumoto T; Boveda-Ruiz D; Gil-Bernabe P; Nagao M; Sugimoto M; Hiraguchi Y; Tokuda R; Naito M; Takagi T; D'Alessandro-Gabazza CN; Suga S; Kobayashi T; Fujisawa T; Taguchi O; Gabazza EC
    PLoS One; 2013; 8(5):e64281. PubMed ID: 23700468
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Ciprofloxacin has antifibrotic effects in scleroderma fibroblasts via downregulation of Dnmt1 and upregulation of Fli1.
    Bujor AM; Haines P; Padilla C; Christmann RB; Junie M; Sampaio-Barros PD; Lafyatis R; Trojanowska M
    Int J Mol Med; 2012 Dec; 30(6):1473-80. PubMed ID: 23041765
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Berbamine inhibits proliferation and induces apoptosis of KU812 cells by increasing smad3 activity.
    Liang Y; Qiu X; Xu RZ; Zhao XY
    J Zhejiang Univ Sci B; 2011 Jul; 12(7):568-74. PubMed ID: 21726064
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. The transforming growth factor beta 1/smad signaling pathway involved in human chronic myeloid leukemia.
    Su E; Han X; Jiang G
    Tumori; 2010; 96(5):659-66. PubMed ID: 21302608
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Histone deacetylase inhibition suppresses the transforming growth factor beta1-induced epithelial-to-mesenchymal transition in hepatocytes.
    Kaimori A; Potter JJ; Choti M; Ding Z; Mezey E; Koteish AA
    Hepatology; 2010 Sep; 52(3):1033-45. PubMed ID: 20564330
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Downregulation of ZEB1 and overexpression of smad7 contribute to resistance to TGF-beta1-mediated growth suppression in adult T-cell leukemia/lymphoma.
    Nakahata S; Yamazaki S; Nakauchi H; Morishita K
    Oncogene; 2010 Jul; 29(29):4157-69. PubMed ID: 20514018
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Prostaglandin E2 as a regulator of germ cells during ovarian development.
    Bayne RA; Eddie SL; Collins CS; Childs AJ; Jabbour HN; Anderson RA
    J Clin Endocrinol Metab; 2009 Oct; 94(10):4053-60. PubMed ID: 19602557
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Effects of the protein kinase inhibitor, imatinib mesylate, on epithelial/mesenchymal phenotypes: implications for treatment of fibrotic diseases.
    Vittal R; Zhang H; Han MK; Moore BB; Horowitz JC; Thannickal VJ
    J Pharmacol Exp Ther; 2007 Apr; 321(1):35-44. PubMed ID: 17218487
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.